APUS insider filings

Apimeds Pharmaceuticals US, Inc. — 27 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-05. Screen APUS transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 3 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Chae Sungjoon — Co-Chief Executive Officer1———
Menon Vin — Co-Chief Executive Officer1———
Sherb Eric Michael — Chief Financial Officer1———

Recent insider filings — Apimeds Pharmaceuticals US, Inc.

FiledFormInsiderReported transactionsSource
2026-11-053Chae Sungjoon — Co-Chief Executive OfficerHoldings only — no transactions reportedEDGAR
2026-11-023Sherb Eric Michael — Chief Financial OfficerHoldings only — no transactions reportedEDGAR
2026-11-023Menon Vin — Co-Chief Executive OfficerHoldings only — no transactions reportedEDGAR
2025-11-214/AInscobee Inc. — 10% ownerHoldings only — no transactions reportedEDGAR
2025-11-134Koo Jakap — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-11-134Yoon Hankil — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-11-134Weintraub Bennett — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-11-134Kogan Elona — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-11-134O'DONNELL CAROL A — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2025-10-244Kogan Elona — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2025-10-214O'DONNELL CAROL A — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2025-10-174Koo Jakap — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2025-10-174Yoon Hankil — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2025-10-174Weintraub Bennett — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2025-10-174Kim Christopher — Chairman and CMO, DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2025-10-174Emerson Erik C. — Chief Executive Officer, DirectorGrant/award (A): 215,000 (derivative) @ $0EDGAR
2025-06-114/AInscobee Inc. — 10% ownerConversion (C): 71,090 @ $2.60 · Conversion (C): 44,041 @ $2.60 · Conversion (C) @ $0 · Conversion (C) @ $0EDGAR
2025-05-204Koo Jakap — DirectorGrant/award (A): 5,780 (derivative) @ $0EDGAR
2025-05-204Weintraub Bennett — DirectorGrant/award (A): 5,780 (derivative) @ $0EDGAR
2025-05-204Yoon Hankil — DirectorGrant/award (A): 5,780 (derivative) @ $0EDGAR
2025-05-204Kim Christopher — Chairman and CMO, DirectorGrant/award (A): 250,000 @ $0EDGAR
2025-05-204Emerson Erik C. — Chief Executive Officer, DirectorGrant/award (A): 750,000 @ $0 · Grant/award (A): 347,279 (derivative) @ $0EDGAR
2025-05-204Kogan Elona — DirectorGrant/award (A): 5,780 (derivative) @ $0EDGAR
2025-05-204O'DONNELL CAROL A — DirectorGrant/award (A): 5,780 (derivative) @ $0EDGAR
2025-05-154Kim Christopher — Chairman and CMO, DirectorPurchase (P): 19,770 @ $1.82 · Purchase (P): 7,730 @ $1.86EDGAR
2025-05-144Koo Jakap — DirectorPurchase (P): 28,500 @ $1.99EDGAR
2025-05-144Inscobee Inc. — 10% ownerPurchase (P): 500,000 @ $4 · Conversion (C): 182,002 @ $2.60 · Conversion (C): 71,090 @ $2.60 · Conversion (C): 44,041 @ $2.60 · Conversion (C) @ $0 · Conversion (C) @ $0 · +1 moreEDGAR

Recent 8-K events — Apimeds Pharmaceuticals US, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-208-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-138-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-298-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-238-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-118-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-218-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-138-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-058-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=APUS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs